AJCN Tufts Nutrition Symposium, Boston & Online Sept 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Delzenne, N. M
Right arrow Articles by Kok, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Delzenne, N. M
Right arrow Articles by Kok, N.
Agricola
Right arrow Articles by Delzenne, N. M
Right arrow Articles by Kok, N.
American Journal of Clinical Nutrition, Vol. 73, No. 2, 456S-458s, February 2001
© 2001 American Society for Clinical Nutrition


Supplement

Effects of fructans-type prebiotics on lipid metabolism1,2,3,4

Nathalie M Delzenne and Nadine Kok

1 From the UCL-Université catholique de Louvain, School of Pharmacy, Brussels.

Several nondigestible but fermentable dietary carbohydrates are able to regulate lipemia and triglyceridemia in both humans and animals. The mechanism of their serum lipid–lowering effect remains to be elucidated. Oligofructose, which is a mixture of nondigestible and fermentable fructans, can decrease triacylglycerol in VLDL when given to rats. The triacylglycerol-lowering action of oligofructose is due to a reduction of de novo fatty acid synthesis in the liver through inhibition of all lipogenic enzymes, namely acetyl-CoA carboxylase (EC 6.4.1.2), fatty acid synthase, malic enzyme (EC 1.1.1.40), ATP citrate lyase (EC 4.1.3.8), and glucose-6-phosphate dehydrogenase (EC 1.1.1.49). Our results suggest that oligofructose decreases lipogenic enzyme gene expression. Postprandial insulin and glucose concentrations are low in the serum of oligofructose-fed animals and this could explain, at least partially, the metabolic effect of oligofructose. Moreover, some events occurring in the gastrointestinal tract after oligofructose feeding could be involved in the antilipogenic effect of this fructan: the production of propionate through fermentation, a modulation of the intestinal production of incretins (namely glucose-dependent insulinotropic peptide and glucagon-like peptide-1), or the modification of the availability of digestible carbohydrates. Recent studies showed that the hypotriglyceridemic effect of fructans also occurs in humans.

Key Words: Triacylglycerol • lipogenesis • fructans • rat • liver




This article has been cited by other articles:


Home page
J. Physiol.Home page
A. D. Maurer, Q. Chen, C. McPherson, and R. A. Reimer
Changes in satiety hormones and expression of genes involved in glucose and lipid metabolism in rats weaned onto diets high in fibre or protein reflect susceptibility to increased fat mass in adulthood
J. Physiol., February 1, 2009; 587(3): 679 - 691.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
N. Salazar, M. Gueimonde, A. M. Hernandez-Barranco, P. Ruas-Madiedo, and C. G. de los Reyes-Gavilan
Exopolysaccharides Produced by Intestinal Bifidobacterium Strains Act as Fermentable Substrates for Human Intestinal Bacteria
Appl. Envir. Microbiol., August 1, 2008; 74(15): 4737 - 4745.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. Benyacoub, F. Rochat, K.-Y. Saudan, I. Rochat, N. Antille, C. Cherbut, T. von der Weid, E. J. Schiffrin, and S. Blum
Feeding a Diet Containing a Fructooligosaccharide Mix Can Enhance Salmonella Vaccine Efficacy in Mice
J. Nutr., January 1, 2008; 138(1): 123 - 129.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. W. Finley, J. B. Burrell, and P. G. Reeves
Pinto Bean Consumption Changes SCFA Profiles in Fecal Fermentations, Bacterial Populations of the Lower Bowel, and Lipid Profiles in Blood of Humans
J. Nutr., November 1, 2007; 137(11): 2391 - 2398.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. A. Vogt, K. B. Ishii-Schrade, P. B. Pencharz, P. J. H. Jones, and T. M. S. Wolever
L-Rhamnose and Lactulose Decrease Serum Triacylglycerols and Their Rates of Synthesis, but Do Not Affect Serum Cholesterol Concentrations in Men
J. Nutr., August 1, 2006; 136(8): 2160 - 2166.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
M. T. Liong and N. P. Shah
Effects of a Lactobacillus casei Synbiotic on Serum Lipoprotein, Intestinal Microflora, and Organic Acids in Rats
J Dairy Sci, May 1, 2006; 89(5): 1390 - 1399.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C.-K. Hsu, J.-W. Liao, Y.-C. Chung, C.-P. Hsieh, and Y.-C. Chan
Xylooligosaccharides and Fructooligosaccharides Affect the Intestinal Microbiota and Precancerous Colonic Lesion Development in Rats
J. Nutr., June 1, 2004; 134(6): 1523 - 1528.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. Busserolles, E. Gueux, E. Rock, C. Demigne, A. Mazur, and Y. Rayssiguier
Oligofructose Protects against the Hypertriglyceridemic and Pro-oxidative Effects of a High Fructose Diet in Rats
J. Nutr., June 1, 2003; 133(6): 1903 - 1908.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
D. Letexier, F. Diraison, and M. Beylot
Addition of inulin to a moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in humans
Am. J. Clinical Nutrition, March 1, 2003; 77(3): 559 - 564.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. Busserolles, E. Gueux, E. Rock, A. Mazur, and Y. Rayssiguier
Substituting Honey for Refined Carbohydrates Protects Rats from Hypertriglyceridemic and Prooxidative Effects of Fructose
J. Nutr., November 1, 2002; 132(11): 3379 - 3382.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. B Roberfroid
Prebiotics: preferential substrates for specific germs?
Am. J. Clinical Nutrition, February 1, 2001; 73(2): 406S - 409.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by The American Society for Nutrition